Prostacyclin vs controlRAP · pulmonary arterial hypertension1 finding from 1 reviewProstacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 1060 participantsModerate
Selexipag vs placeboRAP · pulmonary arterial hypertension1 finding from 1 reviewProstacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 43 participantsModerate